儿童弱视在印度西部的三级眼科护理中心。

IF 1.8 4区 医学 Q2 OPHTHALMOLOGY
International journal of ophthalmology Pub Date : 2025-07-18 eCollection Date: 2025-01-01 DOI:10.18240/ijo.2025.07.21
Jai A Kelkar, Harsh H Jain, Aditya S Kelkar, Shreekant Kelkar
{"title":"儿童弱视在印度西部的三级眼科护理中心。","authors":"Jai A Kelkar, Harsh H Jain, Aditya S Kelkar, Shreekant Kelkar","doi":"10.18240/ijo.2025.07.21","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To describe the demographics, clinical characteristics and treatment outcomes of childhood amblyopia in a tertiary eye center in western India.</p><p><strong>Methods: </strong>This was a retrospective longitudinal hospital-based study of 1382 children aged ≤12y included in the National Institute of OphthalMology AmBlyopia StUdy in Indian Paediatric EyeS (NIMBUS) Study. Data on patient demographics, treatment approach, and best-corrected visual acuity (BCVA) changes were reviewed.</p><p><strong>Results: </strong>The mean age of the study cohort was 4.54±2.46y, with males constituting the majority (55.4%). The cause of amblyopia was refractive error in 73.2%, strabismus in 7.3%, and anisometropia in 6.8% of eyes. The majority of therapies comprised glasses (74.4%), followed by occlusion+glasses (10.3%), occlusion alone (7.3%), and surgery+patching+glasses (5.1%). The mean occlusion time was 2.46±1.14h. After a median follow-up of 10.00 (6-85)mo, the mean BCVA significantly improved from 0.85±0.41 to 0.55±0.42 logMAR. Subgroup analysis revealed BCVA gain for all etiologies, including refractive errors (<i>P</i><0.001), strabismus (<i>P</i><0.001), cataract (<i>P</i><0.001), and ptosis (<i>P</i><0.001). Additionally, eyes with refractive errors showed significantly better BCVA than eyes with cataracts (<i>P</i><0.001), strabismus (<i>P</i><0.001) and marginally better BCVA than eyes with ptosis (<i>P</i><0.05), both at the baseline and final visit.</p><p><strong>Conclusion: </strong>Refractive errors are the commonest cause of amblyopia, followed by strabismus and anisometropia. Timely detection, optimal therapy, and periodic follow-up are crucial in bettering visual acuity regardless of the cause.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 7","pages":"1369-1374"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207316/pdf/","citationCount":"0","resultStr":"{\"title\":\"Childhood amblyopia in a tertiary eye care center in western India.\",\"authors\":\"Jai A Kelkar, Harsh H Jain, Aditya S Kelkar, Shreekant Kelkar\",\"doi\":\"10.18240/ijo.2025.07.21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>To describe the demographics, clinical characteristics and treatment outcomes of childhood amblyopia in a tertiary eye center in western India.</p><p><strong>Methods: </strong>This was a retrospective longitudinal hospital-based study of 1382 children aged ≤12y included in the National Institute of OphthalMology AmBlyopia StUdy in Indian Paediatric EyeS (NIMBUS) Study. Data on patient demographics, treatment approach, and best-corrected visual acuity (BCVA) changes were reviewed.</p><p><strong>Results: </strong>The mean age of the study cohort was 4.54±2.46y, with males constituting the majority (55.4%). The cause of amblyopia was refractive error in 73.2%, strabismus in 7.3%, and anisometropia in 6.8% of eyes. The majority of therapies comprised glasses (74.4%), followed by occlusion+glasses (10.3%), occlusion alone (7.3%), and surgery+patching+glasses (5.1%). The mean occlusion time was 2.46±1.14h. After a median follow-up of 10.00 (6-85)mo, the mean BCVA significantly improved from 0.85±0.41 to 0.55±0.42 logMAR. Subgroup analysis revealed BCVA gain for all etiologies, including refractive errors (<i>P</i><0.001), strabismus (<i>P</i><0.001), cataract (<i>P</i><0.001), and ptosis (<i>P</i><0.001). Additionally, eyes with refractive errors showed significantly better BCVA than eyes with cataracts (<i>P</i><0.001), strabismus (<i>P</i><0.001) and marginally better BCVA than eyes with ptosis (<i>P</i><0.05), both at the baseline and final visit.</p><p><strong>Conclusion: </strong>Refractive errors are the commonest cause of amblyopia, followed by strabismus and anisometropia. Timely detection, optimal therapy, and periodic follow-up are crucial in bettering visual acuity regardless of the cause.</p>\",\"PeriodicalId\":14312,\"journal\":{\"name\":\"International journal of ophthalmology\",\"volume\":\"18 7\",\"pages\":\"1369-1374\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207316/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.18240/ijo.2025.07.21\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.07.21","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:描述印度西部某三级眼科中心儿童弱视的人口统计学、临床特征和治疗结果。方法:这是一项以医院为基础的回顾性纵向研究,1382名年龄≤12岁的儿童纳入了印度国家眼科弱视研究所(NIMBUS)的弱视研究。回顾了患者人口统计学、治疗方法和最佳矫正视力(BCVA)变化的数据。结果:研究队列的平均年龄为4.54±2.46岁,男性占多数(55.4%)。屈光不正占73.2%,斜视占7.3%,屈光参差占6.8%。大多数治疗方法包括眼镜(74.4%),其次是遮挡+眼镜(10.3%),单独遮挡(7.3%)和手术+贴片+眼镜(5.1%)。平均闭塞时间为2.46±1.14h。中位随访10.00(6-85)个月后,平均BCVA从0.85±0.41 logMAR显著改善至0.55±0.42 logMAR。亚组分析显示BCVA在所有病因中均有增加,包括屈光不正(ppppppp)。结论:屈光不正是弱视最常见的原因,其次是斜视和屈光参差。无论病因如何,及时发现、最佳治疗和定期随访对改善视力至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Childhood amblyopia in a tertiary eye care center in western India.

Aim: To describe the demographics, clinical characteristics and treatment outcomes of childhood amblyopia in a tertiary eye center in western India.

Methods: This was a retrospective longitudinal hospital-based study of 1382 children aged ≤12y included in the National Institute of OphthalMology AmBlyopia StUdy in Indian Paediatric EyeS (NIMBUS) Study. Data on patient demographics, treatment approach, and best-corrected visual acuity (BCVA) changes were reviewed.

Results: The mean age of the study cohort was 4.54±2.46y, with males constituting the majority (55.4%). The cause of amblyopia was refractive error in 73.2%, strabismus in 7.3%, and anisometropia in 6.8% of eyes. The majority of therapies comprised glasses (74.4%), followed by occlusion+glasses (10.3%), occlusion alone (7.3%), and surgery+patching+glasses (5.1%). The mean occlusion time was 2.46±1.14h. After a median follow-up of 10.00 (6-85)mo, the mean BCVA significantly improved from 0.85±0.41 to 0.55±0.42 logMAR. Subgroup analysis revealed BCVA gain for all etiologies, including refractive errors (P<0.001), strabismus (P<0.001), cataract (P<0.001), and ptosis (P<0.001). Additionally, eyes with refractive errors showed significantly better BCVA than eyes with cataracts (P<0.001), strabismus (P<0.001) and marginally better BCVA than eyes with ptosis (P<0.05), both at the baseline and final visit.

Conclusion: Refractive errors are the commonest cause of amblyopia, followed by strabismus and anisometropia. Timely detection, optimal therapy, and periodic follow-up are crucial in bettering visual acuity regardless of the cause.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.50
自引率
7.10%
发文量
3141
审稿时长
4-8 weeks
期刊介绍: · International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online). This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166. IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO); Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering. International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al. Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society). Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press). Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). Associate Editors-in-Chief include: Prof. Ning-Li Wang (President Elect of APAO); Prof. Ke Yao (President of Chinese Ophthalmological Society) ; Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ; Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA); Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society); Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA); Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA). IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles, both basic and clinical papers. Instruction is Welcome Contribution is Welcome Citation is Welcome Cooperation organization International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信